SCHEMBL27669249

SCHEMBL27669249

CCOC(=O)c1cc2c(OCC3CN(C(=O)OC(C)(C)C)CCO3)cccc2o1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ EPHA2 P29317 4/20 0.49
▸ ERBB2 P04626 1/20 0.44
▸ EPHB4 P54760 1/20 0.44
▸ PDK1 Q15118 1/20 0.42
▸ NMT2 O60551 1/20 0.42
▸ NMT1 P30419 1/20 0.42
▸ NR1H4 Q96RI1 1/20 0.41
▸ BUB1 O43683 1/20 0.41
▸ CSF1R P07333 1/20 0.39
▸ HTR6 P50406 2/20 0.38
▸ BCHE P06276 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ HRH3 Q9Y5N1 1/20 0.38
▸ GPR119 Q8TDV5 1/20 0.37
▸ P2RX3 P56373 3/20 0.37
▸ P2RX2 Q9UBL9 3/20 0.37
▸ ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27649066 0.84 NMT2 (0.51) EPHA2ERBB2EPHB4NMT2NMT1
SCHEMBL5292472 0.82 EPHA2 (0.43) EPHA2ERBB2EPHB4PDK1CSF1R
SCHEMBL5297191 0.82 EPHA2 (0.43) EPHA2ERBB2EPHB4PDK1CSF1R
SCHEMBL1473383 0.82 EPHA2 (0.43) EPHA2ERBB2EPHB4PDK1CSF1R
SCHEMBL28851224 0.79 EPHA2 (0.51) EPHA2ERBB2EPHB4PDK1NR1H4
SCHEMBL1473531 0.78 KDM4E (0.47) EPHA2ERBB2EPHB4ALDH1A1
SCHEMBL8251140 0.78 KDM4E (0.47) EPHA2ERBB2EPHB4ALDH1A1
SCHEMBL1922160 0.76 SLC6A2 (0.52) EPHA2ERBB2EPHB4PDK1NR1H4
SCHEMBL13482008 0.76 EPHA2 (0.51) EPHA2ERBB2EPHB4PDK1NR1H4
SCHEMBL30725419 0.76 BACE1 (0.49) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100469780-C Cysteine protease inhibitors MEDIVIR AB (SE) 2009-03-18 — — CN disclosed
CN-1918169-A Cysteine protease inhibitors MEDIVIR AB (SE) 2007-02-21 — — CN disclosed
Send feedback